{"name":"Caladrius Biosciences","slug":"caladrius","ticker":"CLBS","exchange":"NASDAQ","domain":"caladrius.com","description":"Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.","hq":"Basking Ridge, NJ","founded":0,"employees":"","ceo":"David Mazzo","sector":"Cell Therapy / Cardiovascular","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$28M","metrics":{"revenue":35283868,"revenueGrowth":56.9,"grossMargin":0,"rdSpend":17680000,"netIncome":-16586000,"cash":17744000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2016"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Caladrius Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"The company reported a net loss of $14.4 million for the fourth quarter and $55.4 million for the full year 2023.","drugName":"","sentiment":"neutral"},{"date":"2023-11-14","type":"deal","headline":"Caladrius Biosciences Announces Collaboration with the University of California, San Francisco (UCSF)","summary":"The company entered into a collaboration with UCSF to develop novel cell therapies for cardiovascular diseases.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-04-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-12","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-21","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxQcllwcTI4WmZzc3Z3dFZSbE1PdDJESHY2V1ZiNEhfYW41aTZnbkdpTjhtNUVXV0JUOVk5R21Zem9MSXVtODR2dkZCb2dfOHhYYjJPTmtRTE9iWEtMZzN3LW9ULU9zdks3OW9FdkNKalEzdkc5bEdVcXU4R0FJR2g5SWFXTFU2Q29aUThmdHowOWI2YmxrMDZlM0ZucW1DdWpjMDJQdEk0S0lJaEVVc1M0U3JRdTU0LTNpZ1BIb1NSdGNERmJQUm1DN2l5QWdfM25VWlRna2hIQkxZNTVJYnJkSnFGYVhWVy1QVlhkZWliVGV1eXpfRi1GOXdOejRLNG0tanN2T0p6SEJsY2dpZDMxUnpSeXBGdw?oc=5","date":"2022-09-15","type":"deal","source":"GlobeNewswire","summary":"Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics - GlobeNewswire","headline":"Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOM01MODU5N3c5dVlUR2preDU3bnRoTUQ2Q1NYZmxscTNWYm56YlVhNnhQM3lhdl9QTEtyajNOdnlPY1ROaTVBZkxPdF9CTzBnY250WWZ2dUVCbm4zckxnZzExVGZIUkxEd0FRMHpMakY5QUJpQ1U0bVFNQ3BydzAwRjlqS0ZQd1RseGpfVV9iTFQ2Z1VGRWlUbGEzSndNZDUzdkxyQmZ2MDFZdFRjSER6Q2laY29RTm1ZbmNVWG53LW1jcUNBVUhGUURYbDZZRF9vS3VpaFNtQmFuTE4ySmhUMkRRU0RmV2FZNlJGRA?oc=5","date":"2022-04-27","type":"deal","source":"GlobeNewswire","summary":"Caladrius Biosciences and Cend Therapeutics Announce Definitive Merger Agreement - GlobeNewswire","headline":"Caladrius Biosciences and Cend Therapeutics Announce Definitive Merger Agreement","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2018-06-20","type":"pipeline","source":"RTTNews","summary":"NEPT Hits A High, CLBS Up 118% In 2 Days, APEN Abuzz, Busy Days Ahead For TSRO - RTTNews","headline":"NEPT Hits A High, CLBS Up 118% In 2 Days, APEN Abuzz, Busy Days Ahead For TSRO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["BioCardia","Cellular Biomedicine Group","Mesoblast"],"therapeuticFocus":["Cardiovascular","Cell Therapy"],"financials":{"source":"sec_edgar+yahoo","revenue":35283868,"revenuePeriod":"2016-12-31","revenueHistory":[{"value":35283868,"period":"2016-12-31"},{"value":22487566,"period":"2015-12-31"},{"value":22487566,"period":"2015-12-31"},{"value":7560,"period":"2015-12-31"},{"value":5888,"period":"2015-09-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":17680000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-16586000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":17744000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}